Entremed (ENMD)

[cycle dude]

Looks like NC is playing close to the vest. The phase I new formulation trial took just 6 weeks. If I recall ENMD sought outside help to address the bioavailability problem. Then surprise,surprise, ENMD chooses a liquid form. If the new formulation is off the charts, I doubt if NC would divulge that info at this juncture. I'm anxiously awaiting that "not too distant future" FDA-new formulation-in-myeloma-trial decision. Anyone have data on how bioavailability results compare from mice to man?